Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
JACC. Cardiovascular Imaging|September 10, 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM TrialMilind Y Desai, Yuichiro Okushi, Kathy Wolski, et al.
Circulation|November 18, 2024
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCMMilind Y Desai, Kathy Wolski, Anjali Owens, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 25, 2021
Endogenous T1ρ cardiovascular magnetic resonance in hypertrophic cardiomyopathyElizabeth W Thompson, Srikant Kamesh Iyer, Michael P Solomon, et al.
Journal of the American College of Cardiology|August 27, 2025
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM TrialMilind Y Desai, Yuichiro Okushi, Shada Jadam, et al.
European Journal of Heart Failure|March 1, 2022
The response to cardiac resynchronization therapy in LMNA cardiomyopathyKiran Sidhu, Anna Isotta Castrini, Victoria Parikh, et al.
Circulation. Heart Failure|May 20, 2025
Antecedent Flu-Like Illness and Onset of Idiopathic Dilated Cardiomyopathy: The DCM Precision Medicine StudyHanyu Ni, Jinwen Cao, Daniel D Kinnamon, et al.
Journal of the American College of Cardiology|May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic CardiomyopathyCarolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.
Journal of the American College of Cardiology|January 4, 2023
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic CardiomyopathyMartin S Maron, Ahmad Masri, Lubna Choudhury, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Sex-Specific Clinical and Genetic Factors Associated With Adverse Outcomes in Hypertrophic CardiomyopathyAlexandra Butters, Clare Arnott, Joanna Sweeting, et al.
Pageof 7